Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Pronovost currently holds 22,970.43 shares of CANTEL MEDICAL CORP (CMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Pronovost has been a net neutral trader of CMD stock. They have purchased $0 and sold $0 worth of shares.
Peter Pronovost's most recent insider trade was on Jun 2, 2021, when they sold 22,970.43 shares at $80.59 per share.
Peter Pronovost serves as Executive at CANTEL MEDICAL CORP (CMD). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Peter Pronovost holds the position of Executive at CANTEL MEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
Peter Pronovost has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Pronovost was on Jun 2, 2021, when they sold $1.9M worth of CMD shares. This transaction involved 22,970.43 shares at $80.59 per share.
Peter Pronovost currently owns 22,970.43 shares of CANTEL MEDICAL CORP (CMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Pronovost's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Pronovost has 9 Form 4 filings on record as an insider at CANTEL MEDICAL CORP.
Set alerts for Peter Pronovost and 40,000+ other insiders.